Ji C - Search Results

1

Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.

Jia L, Yang H, Liu Y, Zhou Y, Li G, Zhou Q, Xu Y, Huang Z, Ye F, Ye J, Liu A, Ji C. Jia L, et al. Among authors: ji c. J Nanobiotechnology. 2024 Apr 22;22(1):198. doi: 10.1186/s12951-024-02460-1. J Nanobiotechnology. 2024. PMID: 38649957 Free PMC article.

2

Smart and Generalizable Cytarabine Derivative-Triggered Nanoparticles for Synergistic Therapy of Relapsed/Refractory Acute Myeloid Leukemia.

Jia L, Yang H, Zheng D, Ye J, Zhou Q, Li G, Zhou Y, Yang X, Liu J, Ye F, Song Y, Ma D, Ji C. Jia L, et al. Among authors: ji c. ACS Appl Mater Interfaces. 2023 Jun 14;15(23):27624-27637. doi: 10.1021/acsami.3c03632. Epub 2023 May 30. ACS Appl Mater Interfaces. 2023. PMID: 37249260

3

DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity.

Zhou Y, Guan L, Li W, Jia R, Jia L, Zhang Y, Wen X, Meng S, Ma D, Zhang N, Ji M, Liu Y, Ji C. Zhou Y, et al. Among authors: ji c, ji m. Cancer Lett. 2022 May 1;533:215608. doi: 10.1016/j.canlet.2022.215608. Epub 2022 Feb 28. Cancer Lett. 2022. PMID: 35240234 Free article.

4

Subclones of bone marrow CD34⁺ cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy.

Jia R, Ji M, Li G, Xia Y, Guo S, Li P, Sun Y, Lu F, Zhang J, Zang S, Yan S, Ye J, Xue F, Ma D, Sun T, Ji C. Jia R, et al. Among authors: ji c, ji m. Cancer. 2022 Nov 15;128(22):3929-3942. doi: 10.1002/cncr.34481. Epub 2022 Oct 5. Cancer. 2022. PMID: 36197314 Free PMC article.

5

DEX-Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T-Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy.

Jia R, Sun T, Zhao X, Li G, Xia Y, Zhou Y, Li W, Li W, Ma D, Ye J, Ji M, Ji C. Jia R, et al. Among authors: ji c, ji m. Adv Sci (Weinh). 2023 Jul;10(19):e2205854. doi: 10.1002/advs.202205854. Epub 2023 Apr 18. Adv Sci (Weinh). 2023. PMID: 37072664 Free PMC article.

6

Spatial single cell analysis of tumor microenvironment remodeling pattern in primary central nervous system lymphoma.

Xia Y, Sun T, Li G, Li M, Wang D, Su X, Ye J, Ji C. Xia Y, et al. Among authors: ji c. Leukemia. 2023 Jul;37(7):1499-1510. doi: 10.1038/s41375-023-01908-x. Epub 2023 Apr 29. Leukemia. 2023. PMID: 37120690 Free PMC article.

7

Immune checkpoint-related gene polymorphisms are associated with acute myeloid leukemia.

Wu Y, Li M, Meng G, Ma Y, Ye J, Sun T, Ji C. Wu Y, et al. Among authors: ji c. Cancer Med. 2023 Sep;12(18):18588-18596. doi: 10.1002/cam4.6468. Epub 2023 Aug 21. Cancer Med. 2023. PMID: 37602517 Free PMC article.

8

Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia.

Li W, Ji M, Lu F, Pang Y, Dong X, Zhang J, Li P, Ye J, Zang S, Ma D, Ji C. Li W, et al. Among authors: ji c, ji m. Cell Death Dis. 2018 Aug 28;9(9):855. doi: 10.1038/s41419-018-0900-7. Cell Death Dis. 2018. PMID: 30154435 Free PMC article.

9

[Study of fibrinolysis inhibitors in 117 acute leukemia patients].

Wang W, Ji CY, Ye JJ, Zhu YY, Guo DM, Ji M. Wang W, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Mar;29(3):183-6. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18788619 Chinese.

10

METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4.

Li M, Ye J, Xia Y, Li M, Li G, Hu X, Su X, Wang D, Zhao X, Lu F, Li J, Ma D, Sun T, Ji C. Li M, et al. Among authors: ji c. Leukemia. 2022 Nov;36(11):2586-2595. doi: 10.1038/s41375-022-01696-w. Epub 2022 Oct 20. Leukemia. 2022. PMID: 36266324 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,205 results

Search Page